Post-marketing Safety Evaluation of Pneumococcal Vaccines Among Children and Elderly Adults.
Conditions
- Pneumococcal Vaccine Adverse Reaction
Interventions
- BIOLOGICAL: 10 or 13-valent pneumococcal conjugate vaccine
- BIOLOGICAL: 23-valent pneumococcal polysaccharide vaccine
- BIOLOGICAL: Influenza vaccine
Sponsor
Sungkyunkwan University
Collaborators